About the Neuroendocrine Tumors Session
Neuroendocrine tumors (NETs) are a complex group of neoplasms originating from neuroendocrine cells, which are found throughout the body, especially in the digestive system and lungs. Despite being relatively rare, their incidence is rising, presenting challenges in diagnosis and treatment. Cancer research in this field aims to understand the molecular mechanisms driving NETs' development and progression, seeking novel diagnostic markers and targeted therapies. Recent advancements include the identification of specific genetic mutations and signaling pathways involved in NETs, paving the way for personalized treatment approaches. Additionally, ongoing studies explore the role of immunotherapy and combination treatments to improve outcomes for patients with advanced or metastatic disease. As research continues, the ultimate goal is to enhance early detection strategies and develop more effective therapeutic options to improve survival rates and quality of life for individuals affected by NETs.
Topics Covered in Neuroendocrine Tumors
Lung Carcinoids
Pancreatic Islet Tumors
Carcinoid Syndrome
Proliferation Grading
Somatostatin Receptor Imaging
Radionuclide Therapy
Related Scientific Sessions at CIOC 2027
Why Attend the Neuroendocrine Tumors Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Neuroendocrine Tumors work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Neuroendocrine Tumors research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Neuroendocrine Tumors track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Neuroendocrine Tumors Conference 2027 — FAQs
What is the Neuroendocrine Tumors track at CIOC 2027?
The Neuroendocrine Tumors track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Neuroendocrine Tumors. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Neuroendocrine Tumors sessions?
Cancer researchers and clinicians, educators and students with an interest in Neuroendocrine Tumors are all welcome — whether presenting or attending.
Can I present my research in the Neuroendocrine Tumors track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Neuroendocrine Tumors sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Neuroendocrine Tumors track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.